Position
SIMPLEX TRADING, LLC in Krystal Biotech, Inc.
Back to the book · All holders of KRYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $589$246.54 → $258.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 293 | $72.2K | — | — | — | 0.0% |
| Q1 2026 | 50 | $12.9K | $258.32 | $589 | −$59.9K | 0.0% |